Natera is a global diagnostics company that develops and commercializes cell-free DNA and other genetic testing technologies for clinical applications. The company focuses on three principal areas: reproductive health (including non-invasive prenatal testing and carrier screening), oncology (tumor-informed assays for minimal residual disease and recurrence monitoring), and organ transplantation (cell-free DNA tests to detect allograft injury). Natera combines laboratory testing, proprietary bioinformatics, and clinical reporting to deliver personalized genetic information to clinicians and patients.
Key product offerings include Panorama, a non-invasive prenatal test that screens for fetal chromosomal abnormalities and select single-gene conditions; Horizon carrier screening for inherited conditions; Signatera, a personalized, tumor-informed assay used for detecting minimal residual disease and monitoring treatment response in cancer patients; and Prospera, a donor-derived cell-free DNA test used to assess the risk of organ rejection. The company also provides genetic counseling and supports clinical use through validation studies and peer-reviewed publications.
Natera operates certified clinical laboratories and serves healthcare providers, hospitals, fertility clinics, and biopharmaceutical partners in the United States and in international markets. The company engages in collaborations with clinicians and drug developers to support clinical trials, companion diagnostic development, and translational research. Its offerings are positioned to support both clinical decision-making and research applications across multiple therapeutic areas.
Founded in the mid-2000s and headquartered in the San Francisco Bay Area, Natera is a publicly traded company listed on the Nasdaq. The business emphasizes ongoing research and product development, regulatory compliance, and scientific validation to expand the clinical utility of its genetic testing platforms. Its leadership and scientific teams comprise professionals with experience in genomics, diagnostics, and laboratory medicine.